124 related articles for article (PubMed ID: 30029936)
1. Indoleamine 2, 3-dioxygenase and B7-H1 expressions as prognostic and follow-up markers in human pancreatic carcinoma.
Wang L; Ma Q; Li D; Mu S; Li Y; Wang Y; Shi P; Yu H; Gao C; Guo K; Zhang Z
Pathol Res Pract; 2018 Sep; 214(9):1309-1314. PubMed ID: 30029936
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of B7-H1 and B7-1 expressions in pancreatic carcinoma.
Wang L; Ma Q; Chen X; Guo K; Li J; Zhang M
World J Surg; 2010 May; 34(5):1059-65. PubMed ID: 20145927
[TBL] [Abstract][Full Text] [Related]
3. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.
Zhang T; Tan XL; Xu Y; Wang ZZ; Xiao CH; Liu R
Chin Med J (Engl); 2017 Mar; 130(6):710-716. PubMed ID: 28303855
[TBL] [Abstract][Full Text] [Related]
4. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine-2,3-Dioxygenase in Non-Small Cell Lung Cancer: A Targetable Mechanism of Immune Resistance Frequently Coexpressed With PD-L1.
Volaric A; Gentzler R; Hall R; Mehaffey JH; Stelow EB; Bullock TN; Martin LW; Mills AM
Am J Surg Pathol; 2018 Sep; 42(9):1216-1223. PubMed ID: 29901571
[TBL] [Abstract][Full Text] [Related]
6. Immune sculpting of norepinephrine on MHC-I, B7-1, IDO and B7-H1 expression and regulation of proliferation and invasion in pancreatic carcinoma cells.
Wang L; Liu H; Chen X; Zhang M; Xie K; Ma Q
PLoS One; 2012; 7(9):e45491. PubMed ID: 23029049
[TBL] [Abstract][Full Text] [Related]
7. [Expression of B7-H1 protein in human pancreatic carcinoma tissues and its clinical significance].
Chen XL; Yuan SX; Chen C; Mao YX; Xu G; Wang XY
Ai Zheng; 2009 Dec; 28(12):1328-32. PubMed ID: 19958630
[TBL] [Abstract][Full Text] [Related]
8. Landscape of Immune Checkpoint Inhibition in Carcinosarcoma (MMMT): Analysis of IDO-1, PD-L1 and PD-1.
Hacking S; Chavarria H; Jin C; Perry A; Nasim M
Pathol Res Pract; 2020 Apr; 216(4):152847. PubMed ID: 32085927
[TBL] [Abstract][Full Text] [Related]
9. Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas.
Mitsuka K; Kawataki T; Satoh E; Asahara T; Horikoshi T; Kinouchi H
Neurosurgery; 2013 Jun; 72(6):1031-8; discussion 1038-9. PubMed ID: 23426156
[TBL] [Abstract][Full Text] [Related]
10. IDO expression in breast cancer: an assessment of 281 primary and metastatic cases with comparison to PD-L1.
Dill EA; Dillon PM; Bullock TN; Mills AM
Mod Pathol; 2018 Oct; 31(10):1513-1522. PubMed ID: 29802358
[TBL] [Abstract][Full Text] [Related]
11. Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study.
Choe JY; Yun JY; Jeon YK; Kim SH; Park G; Huh JR; Oh S; Kim JE
BMC Cancer; 2014 May; 14():335. PubMed ID: 24886161
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer.
Wang Y; Lin J; Cui J; Han T; Jiao F; Meng Z; Wang L
Oncotarget; 2017 Feb; 8(6):9354-9365. PubMed ID: 28030840
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma.
Rosenbaum MW; Gigliotti BJ; Pai SI; Parangi S; Wachtel H; Mino-Kenudson M; Gunda V; Faquin WC
Endocr Pathol; 2018 Mar; 29(1):59-67. PubMed ID: 29372535
[TBL] [Abstract][Full Text] [Related]
14. Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma.
Wei YF; Chu CY; Chang CC; Lin SH; Su WC; Tseng YL; Lin CC; Yen YT
Lung Cancer; 2018 Nov; 125():35-42. PubMed ID: 30429036
[TBL] [Abstract][Full Text] [Related]
15. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer.
Shen L; Qian Y; Wu W; Weng T; Wang FXC; Hong B; Wu Z; Wang Q; Sang Y; Zhang H; Zhou X; Yao H
Hum Pathol; 2017 Aug; 66():79-85. PubMed ID: 28600225
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma.
Ben-Haj-Ayed A; Moussa A; Ghedira R; Gabbouj S; Miled S; Bouzid N; Tebra-Mrad S; Bouaouina N; Chouchane L; Zakhama A; Hassen E
Immunol Lett; 2016 Jan; 169():23-32. PubMed ID: 26608400
[TBL] [Abstract][Full Text] [Related]
17. Localization of indoleamine 2,3-dioxygenase in human esophageal squamous cell carcinomas.
Liu J; Lu G; Tang F; Liu Y; Cui G
Virchows Arch; 2009 Nov; 455(5):441-8. PubMed ID: 19844741
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer.
Ino K; Yoshida N; Kajiyama H; Shibata K; Yamamoto E; Kidokoro K; Takahashi N; Terauchi M; Nawa A; Nomura S; Nagasaka T; Takikawa O; Kikkawa F
Br J Cancer; 2006 Dec; 95(11):1555-61. PubMed ID: 17117179
[TBL] [Abstract][Full Text] [Related]
19. Prognostic values of B7-H3, B7-H4, and HHLA2 expression in human pancreatic cancer tissues based on mIHC and spatial distribution analysis.
Zhu Y; Chen J; Liu Y; Zheng X; Feng J; Chen X; Jiang T; Li Y; Chen L
Pathol Res Pract; 2022 Jun; 234():153911. PubMed ID: 35489125
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of PD-1 and PD-L1 expression in patients with metastatic clear cell renal cell carcinoma.
Ueda K; Suekane S; Kurose H; Chikui K; Nakiri M; Nishihara K; Matsuo M; Kawahara A; Yano H; Igawa T
Urol Oncol; 2018 Nov; 36(11):499.e9-499.e16. PubMed ID: 30131293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]